Home > List All Publishers > Biopharm Knowledge Publishing

Biopharm Knowledge Publishing

Biopharm Knowledge Publishing specializes in the issues involved in outsourcing, clinical trials and drug development. It is the publisher of the Biopharm Outsourcing Register, a unique, global, database of Contract Research Organisations. More than 1400 organisations are included in the database and Biopharm uses the expertise and knowledge developed in producing this information source to produce a series of reports linked to the issues surrounding outsourcing, clinical trials and drug development. It has built up a group of editors and writers who contribute their expertise to a series of detailed and comprehensive reports which are vital reading for anyone involved in drug development.

List of reports from Biopharm Knowledge Publishing

Central and Core Laboratories: The Definitive Guide to the Current Status and Future Prospects of Central Clinical Pathology, ECG and Imaging Laboratories 10/1/2011 \| published by: Biopharm Knowledge Publishing ... fascinating history of clinical pathology and shows how this medical analysis "lab tests", has come to form the basis of the global central laboratory business. Today much of the clinical development of new drugs is ... \| more... Search inside this report	$1,850.00
Contract Research Annual Review 2011 6/21/2011 \| published by: Biopharm Knowledge Publishing ... fall by more than 50%. The industry is rapidly re-shaping itself to match the changing needs of a pharmaceutical industry that is realigning its R&D strategies to improve effectiveness and to face a new set ... \| more... Search inside this report	$585.00
Toxicology and Pharmacology 1/12/2010 \| published by: Biopharm Knowledge Publishing ... by regulatory bodies around the world, the processes involved, especially animal testing, remain controversial. Almost all of the work is outsourced and the major companies involved have come under considerable pressure from activist groups. This ... \| more... Search inside this report	$1,645.00
Generics in Japan 11/24/2009 \| published by: Biopharm Knowledge Publishing ... nations Japan has an ageing population and ageing populations take a disproportionate share of healthcare spend. For Japan the problem is very marked; it has the highest life expectancy of any major country and spends ... \| more... Search inside this report	$2,995.00
Systems Biology 7/8/2009 \| published by: Biopharm Knowledge Publishing ... more fundamental problem is the failure of major companies to discover, develop and market new drugs. Major drugs losing patent protection or being withdrawn from the market are simply not being replaced by new therapies ... \| more... Search inside this report	$2,345.00
Quality for Biologics 1/1/2009 \| published by: Biopharm Knowledge Publishing ... accounting for more than 25% of launches in 2007. But biologics are not like small molecules - they are more complex to develop, test and produce. Any change in production may have a direct effect ... \| more... Search inside this report	$2,325.00
Virtual Pharma 9/10/2008 \| published by: Biopharm Knowledge Publishing ... biggest companies are growing slowly, if at all. Against that background pharmaceutical companies, large and small, are looking for new ways to do business - ways that will bring success in a difficult market. For ... \| more... Search inside this report	$1,495.00
EvaluatePharma Yearbook 7/16/2008 \| published by: Biopharm Knowledge Publishing ... which are suffering in changing circumstances. The EvaluatePharma® Yearbook gives you the information that you need, in context. The Yearbook provides information and data of the highest quality, taken directly from the EvaluatePharma® database and ... \| more... Search inside this report	$2,885.00
The Rise of Mid-Sized Pharma 5/23/2008 \| published by: Biopharm Knowledge Publishing ... and are performing much better on the world’s stock markets. The reasons behind that success are key to a full understanding of the pharmaceutical industry - and to its future growth. This new report, published ... \| more... Search inside this report	$1,565.00
Cardiac Toxicity 3/28/2008 \| published by: Biopharm Knowledge Publishing ... period. The consequences for the global pharmaceutical industry can be huge, with major drugs being withdrawn and companies being sued for negligence. But often cardiac events are so rare that they may only be found ... \| more... Search inside this report	$2,950.00
Immunogenicity to Biologics 10/19/2007 \| published by: Biopharm Knowledge Publishing ... This comprehensive new report, written by industry experts, gives you the information you need to understand this vital subject and includes a chapter on the commercial implications written by PricewaterhouseCoopers (PWC). This unique, 170-page report, ... \| more... Search inside this report	$2,900.00
Biosimilars 11/28/2006 \| published by: Biopharm Knowledge Publishing ... by PricewaterhouseCoopers (PwC) looking at the commercial implications for the biotech and pharmaceutical markets. The market for biotech drugs grew by 18% in 2005 and now exceeds $50 billion - that’s 10% of the global ... \| more... Search inside this report	$2,160.00